← Back to all trials
Completed
NCT07694947
Changes in Eosinophil Cationic Protein and Sputum Eosinophils Following Allergen Immunotherapy
Conditions: Allergic Asthma
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 100
Sponsor: Mansoura University Hospital
Location: Mohamed AbdElmoniem Al Mansurah
Summary
Asthma is a chronic heterogeneous inflammatory airway disease affecting millions worldwide and remains a major global health burden. Despite advances in pharmacological therapy, a substantial proportion of patients continue to experience uncontrolled symptoms due to persistent airway inflammation and disease heterogeneity.
Eligibility Criteria
Inclusion Criteria:
* Age above 18 years and diagnosed of allergic asthma. Patients were clinical stabile and confirmed diagnosis supported by pulmonary function test.
Exclusion Criteria:
* pregnant
* parasitic infestations
* recent acute asthma exacerbation
* current smoking
* severe persistent asthma
Source: ClinicalTrials.gov (NCT07694947). StuddyBuddy aggregates publicly available trial information.
